# Pharmacokinetics of Venetoclax in Patients With Chronic Lymphocytic Leukemia

> **NCT04616274** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Venetoclax

## Key facts

- **NCT ID:** NCT04616274
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2021-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04616274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04616274, "Pharmacokinetics of Venetoclax in Patients With Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04616274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*